Page last updated: 2024-08-24

fluorodopa f 18 and Benign Neoplasms

fluorodopa f 18 has been researched along with Benign Neoplasms in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ametamey, SM; Franck, D; Keller, C; Krämer, SD; Kuznetsova, OF; Mu, L; Müller, A; Müller, C; Ross, TL; Schibli, R; Schweinsberg, C	1
de Vries, EG; Elsinga, PH; Jager, PL; Kema, IP; Koopmans, KP; Neels, OC; Sluiter, WJ; van der Horst-Schrivers, AN	1
Ell, PJ; Groves, AM; Haim, SB; Win, T	1
Vallabhajosula, S	1
Graham, MM	1

Reviews

2 review(s) available for fluorodopa f 18 and Benign Neoplasms

Article	Year
Non-[18F]FDG PET in clinical oncology. The Lancet. Oncology, 2007, Volume: 8, Issue:9 Topics: Antibodies; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Medical Oncology; Neoplasms; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Receptors, Somatostatin	2007
(18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization. Seminars in nuclear medicine, 2007, Volume: 37, Issue:6 Topics: Amino Acids; Animals; Bone and Bones; Cell Hypoxia; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Estradiol; Fluorine Radioisotopes; Fluoroacetates; Fluorodeoxyglucose F18; Glucose; Humans; Membrane Lipids; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2007

Article

Year

Non-[18F]FDG PET in clinical oncology.

The Lancet. Oncology, 2007, Volume: 8, Issue:9

Topics: Antibodies; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Medical Oncology; Neoplasms; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Receptors, Somatostatin

2007

(18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.

Seminars in nuclear medicine, 2007, Volume: 37, Issue:6

Topics: Amino Acids; Animals; Bone and Bones; Cell Hypoxia; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Estradiol; Fluorine Radioisotopes; Fluoroacetates; Fluorodeoxyglucose F18; Glucose; Humans; Membrane Lipids; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed

2007

Other Studies

3 other study(ies) available for fluorodopa f 18 and Benign Neoplasms

Article	Year
5-(2-18F-fluoroethoxy)-L-tryptophan as a substrate of system L transport for tumor imaging by PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:3 Topics: Amino Acid Transport System L; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Cell Line, Tumor; Cells, Cultured; Dihydroxyphenylalanine; Enzyme Inhibitors; Female; Image Processing, Computer-Assisted; Isotope Labeling; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Serum Albumin; Tissue Distribution; Tryptophan	2012
Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study. The Lancet. Oncology, 2006, Volume: 7, Issue:9 Topics: Adult; Aged; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, Somatostatin; Reproducibility of Results; Somatostatin; Tomography, X-Ray Computed	2006
Combined 18F-FDG-FDOPA tumor imaging for assessing response to therapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:2 Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2001